Concept Model, Attribute and Values Component: CMAG prioritisation May 2017

Concept Model, Attribute and Values Component: CMAG prioritisation May 2017

The results have been presented in order of the priority assigned (using the average of the results).

The green rows are issues that already have an assignee. 

 

Key

 

Summary

UK

CA

AN

AU

AVG

Range

UK

Canada

Netherlands

Australia

IHTSDO-446

artf221498-Revise procedure model to cleanly distinguish means, need (focus), and desired/expected outcome

3.00

N/A

3.00

2.33

2.78

0.67

 

 

 

 

IHTSDO-773

artf228875-Otitis - review and correction of inconsistencies, duplicates, modeling

3.00

3.00

2.33

2.33

2.67

0.67

Highly used content, significant clinical area.

This is such a frequent used dx, it should be fixed asap

 

 

IHTSDO-987

|Method| attribute target values: |Examination-action|, |Measurement-action|- review of use

3.00

N/A

2.33

2.67

2.67

0.67

This item focuses on |Method| attribute target values |examination-action| , |Measurement-action so would involve a lot of high use content.  So caution would also be needed because of this.

 

 

 

IHTSDO-967

Concept model for secondary disorders

3.00

N/A

2.67

2.33

2.67

0.67

 

IHTSDO-556 X with Y, X due to Y is closed. What is the difference with this RFC?

 

 

IHTSDO-678

artf6235-Observable and Attribute semantic duality

3.00

N/A

2.67

2.33

2.67

0.67

User confusion with current status I would think.

 

 

 

IHTSDO-844

artf6314-Immunization and vaccination

2.67

3.00

2.33

2.33

2.58

0.67

 

How much of this content can be prioritized while the substance Re-design is now addressing Substances issues?

 

 

IHTSDO-970

Revision of existing content to proximal primitive modeling style by applying authoring form algorithm

3.00

3.00

1.67

N/A

2.56

1.33

Large volume so will contain high priority clinical areas.  Impact on user in terms of changed content high but resulting in better subsumption based queries.

This needs to be undertaken as soon as possible, although there might be some benefit to chunck this project in smaller piece, especially because it will most likely impact extensions and existing projects

 

I'll abstain, just due to my view on PPM :)

IHTSDO-558

artf221697-PATHOLOGIC PROCESS

3.00

N/A

2.33

2.33

2.56

0.67

 

 

 

 

IHTSDO-974

Review of the |Monitoring procedure (regime/therapy)| sub hierarchy with model development

3.00

N/A

2.67

2.00

2.56

1.00

525 descendents.  Significant task to develop a concept model.  Lot of high priority health areas here.

 

 

 

IHTSDO-571

artf6255-SEVERITY

2.67

2.67

2.33

2.33

2.50

0.33

 

Large releated other RFC, but blocking 1 RFC, but high priority for QV

 

 

IHTSDO-114

artf6181-Morphology = acute inflammation, chronic inflammation

2.00

3.00

2.33

2.67

2.50

1.00

 

This is also quite basic elements that need to be of high quality. To do asap.

Same problem as occurrence. Important to solve this for consistency in concepts and hierarchy and correct classifying

 

IHTSDO-812

artf222657-New attribute: Associated device

2.33

N/A

2.67

2.33

2.44

0.33

Noted that:
Potential confusion: ASSOCIATED WITH = device, vs ASSOCIATED DEVICE = device. 

 

 

 

IHTSDO-407

artf6299-Frequencies and Courses: recurrent, relapsing, continuous, intermittent, daily, etc

2.67

N/A

2.00

2.67

2.44

0.67

 

 

 

6265==6299

IHTSDO-323

artf6265-Frequency and course

2.67

N/A

2.00

2.67

2.44

0.67

Linked to IHTSDO407 above

 

 

6265==6299

IHTSDO-181

artf6176-Disorders with a role group that has more than one Attribute of a kind.

2.67

3.00

2.33

1.67

2.42

1.33

Blocked by IHTSDO347 but important for QA

This needs to be undertaken as soon as possible, although there might be some benefit to chunck this project in smaller piece, especially because it will most likely impact extensions and existing projects

 

 

IHTSDO-867

artf6252-OCCURRENCE

2.67

N/A

2.33

2.00

2.33

0.67

Large scale use of this attribute.

 

Important to solve this for consistency in concepts and hierarchy and correct classifying

 

IHTSDO-849

artf6232-HAS INTENT

2.33

N/A

2.33

2.33

2.33

0.00

 

 

Important to solve this for consistency in concepts and hierarchy and correct classifying

676==849

IHTSDO-807

artf6244-ACCESS

2.67

N/A

2.33

2.00

2.33

0.67

 

 

 

 

IHTSDO-947

New attributes: 'Associated with' attribute hierarchy_Representing temporal associations between procedures and their related disorders.

2.00

N/A

2.67

2.33

2.33

0.67

 

 

 

This has actually progressed.. There's at least a "during" attribute now .

IHTSDO-986

Modelling of seizure concepts

3.00

N/A

2.67

1.33

2.33

3.00

262 concepts that would require review.  Review in terms of modelling and semantic tag is no small task.  Possible duplication of content which is why I thought high clinical impact.

 

 

 

IHTSDO-780

artf6231-Procedure named by intended outcome

2.33

N/A

2.67

1.67

2.22

1.00

 

 

Overlap with the has intent attribute review

 

IHTSDO-608

artf6253-Imperatives

2.33

N/A

2.33

2.00

2.22

0.33

It is a significant change from current policy though.  Could result in a high number of requests for additional content.

This is labelled as a small project, when in fact it can be blown… perharps a more focussed starting point should be identified to constraint the resources better

 

 

IHTSDO-676

artf222711-Add in a role group: "Has intent"

2.00

3.00

1.33

2.33

2.17

1.67

 

Many related Tracker items

 

676==849

IHTSDO-347

artf6175-Relationship grouping: policy and content revision

2.67

N/A

N/A

1.67

2.17

1.00

 

 

 

 

IHTSDO-1000

Review of the range for the Associated finding attribute

2.67

N/A

1.67

2.00

2.11

1.00

Impact on HL7 users (use ofn Link asssertion)

I'M not sure I understand this request and its impact

 

 

IHTSDO-619

artf222816-Review concept model: Screening intent vs. Screening type

2.67

N/A

1.67

2.00

2.11

1.00

 

 

 

 

IHTSDO-333

artf230630-Allowance of "process" as an allowed value for attribute "due to"

2.67

N/A

2.00

1.67

2.11

1.00

Uncertain about terminology impact really but as this is an attibute then scored 3

 

 

 

IHTSDO-62

artf222769-New attribute METHOD ACCESS

2.33

N/A

2.00

2.00

2.11

0.33

 

 

 

 

IHTSDO-525

artf6211-Context values for actions

3.00

2.00

2.00

1.33

2.08

1.67

High volume content.  Procedure context Important for Care Planning International Model

 

 

No really sure that this is about - though actions are important...

IHTSDO-741

artf6174-SUBJECT RELATIONSHIP CONTEXT values

2.67

N/A

1.33

N/A

2.00

1.33

 

 

 

 

IHTSDO-726

artf6319-consistently put HAS FOCUS in role groups

2.67

N/A

1.33

2.00

2.00

1.33

 

What is the impact if the attribute is not grouped? If minor, keep low priority

 

 

IHTSDO-273

artf222748-Review concepts: Intent actions vs. Means actions

2.33

N/A

1.67

2.00

2.00

0.67

 

 

 

 

IHTSDO-744

artf6249-USING ENERGY

2.67

2.00

1.67

1.33

1.92

1.33

Potentially clinically important in energy source queries e.g. for radiation exposure.

If this was not fully implemented since 2007, how urgent is this?

 

 

IHTSDO-341

artf6263-New attribute: SITE OF ORIGIN (of embolus, metastasis, etc)

2.00

1.33

2.33

2.00

1.92

1.00

 

How urgent is this?

 

 

IHTSDO-858

artf6279-definition of grouper, whitelisting of exceptions to MRCM rules in User Guide

3.00

1.00

N/A

1.67

1.89

2.00

Risk for groupers to be used wrongly in clinical record so important to define these.

Low priority

 

 

IHTSDO-216

artf6273-percutaneous

1.67

2.67

1.33

1.67

1.83

1.33

 

Large releated other RFC, but blocking 2 RFC, but high priority for QV

 

 

IHTSDO-940

artf6246-FINDING METHOD

2.67

N/A

1.00

1.67

1.78

1.67

Over 3500 concepts in some high use areas though not sure clinical impact would be high.

 

 

 

IHTSDO-1009

What does "dysfunction" mean. Concepts are primitive

2.00

1.33

2.33

1.33

1.75

1.00

 

How urgent is this?

 

 

IHTSDO-219

artf6248-USING SUBSTANCE

1.33

N/A

2.00

1.67

1.67

0.67

Copyright © 2025, SNOMED International